A combined therapy of Meropenem-ZnO-nanoparticles efficiently eliminates carbapenem-resistant Klebsiella pneumoniae (CRKP) biofilms, with reduced nephrotoxicity (in vitro)

In response to the World Health Organization's (WHO) research agenda of antimicrobial resistance (AMR) in human health, this study appraised the antibacterial and antibiofilm synergistic activity of meropenem and ZnO-NPs combination against carbapenem-resistant Klebsiella pneumoniae (CRKP). The minimum inhibitory concentration (MIC) of meropenem in combination was found to be approximately 1/12 of its MIC alone. The results of microtiter dilution assay showed that the combination was more efficient in reducing the biofilm biomass than meropenem alone or ZnO-NPs alone. The scanning-electron-microscopy (SEM) micrographs elucidated that the combination of meropenem with ZnO-NPs has significantly enhanced its competence in eradicating the preformed biofilms of CRKP strains. In addition, the relative gene expression results showed that the combination compared to the meropenem alone and ZnO-NPs alone eloquently down-regulated the expression of biofilm genes (mrkA, fimA, and ecpA). Besides, the MTT-assay demonstrated that the combination has limited cytotoxicity against Vero-cells (in vitro). Overall, this study represents an efficient safe enhancement of meropenem to tackle the growing health threat of CRKP and carbapenem-resistant Enterobacterals (CRE) prevalence.